Expertise in
9
conditions

Felipe Prosper

Pamplona, NC, ES 
Expertise in
9
conditions
Pamplona, NC, ES 

Overview

Felipe Prosper practices practicing medicine in Pamplona, Spain.

Mr. Prosper is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Acute Myeloid Leukemia (AML), Leukemia, and Tenotomy.

He is actively involved in clinical research, co-authoring 353 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Pamplona, NC, Spain
Other Locations
Madrid, MD, Spain
Spain
San Sebastian, PV, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Clinical Trial Phase I / II Graft Versus Host Disease Treatment Refractory to First-line Therapy With Sequential Infusion of Mesenchymal Cells Allogeneic Expanded Adipose Tissue in Vitro
Clinical Trial Phase I / II Graft Versus Host Disease Treatment Refractory to First-line Therapy With Sequential Infusion of Mesenchymal Cells Allogeneic Expanded Adipose Tissue in Vitro
Enrollment Status: Completed
Publish Date: October 13, 2022
Intervention Type: Drug
Study Drug: Adult Allogeneic Mesenchymal Cells from Adipose Tissue
Study Phase: Phase 1/Phase 2
Phase II Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide
Phase II Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide
Enrollment Status: Terminated
Publish Date: December 02, 2020
Intervention Type: Drug
Study Phase: Phase 2
Phase I Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
Phase I Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
Enrollment Status: Completed
Publish Date: October 12, 2020
Intervention Type: Drug
Study Phase: Phase 1
Multicentre,Randomized,Comparative,Add-on,Into Two Parallel Groups Clinical Trial to Evaluate Efficacy and Safety of Autologous Mesenchymal Stem Cells Derived From Expanded Adipose Tissue (ASC), for Treatment of Complex Perianal Fistulizing Disease in Patients Without IBD.
Multicentre,Randomized,Comparative,Add-on,Into Two Parallel Groups Clinical Trial to Evaluate Efficacy and Safety of Autologous Mesenchymal Stem Cells Derived From Expanded Adipose Tissue (ASC), for Treatment of Complex Perianal Fistulizing Disease in Patients Without IBD.
Enrollment Status: Completed
Publish Date: April 19, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

353 Total Publications

Preparation of Formalin-Fixed, Paraffin-Embedded Bone Marrow Samples for Spatial Transcriptomics Using EDTA-Based Decalcification.
Preparation of Formalin-Fixed, Paraffin-Embedded Bone Marrow Samples for Spatial Transcriptomics Using EDTA-Based Decalcification.
Journal: Journal of visualized experiments : JoVE
Published: August 29, 2026

Frequently Asked Questions about Felipe Prosper

Is Felipe Prosper a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Felipe Prosper is classified as an Elite expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Felipe Prosper participate in research or clinical trials?

Yes. Felipe Prosper has published 353 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Felipe Prosper's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Prosper's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 44 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile